Solvezink (Zinc Sulfate)

What Is Solvezink and What Is It Used For?

Quick Answer: Solvezink is a prescription effervescent zinc supplement containing 45 mg of elemental zinc as zinc sulfate. It is used to treat zinc deficiency, promote healing of venous leg ulcers, and manage acrodermatitis enteropathica, a rare hereditary condition.

Solvezink contains zinc sulfate, providing 45 milligrams of elemental zinc (Zn²⁺) per effervescent tablet. Zinc is a naturally occurring trace element found in small amounts throughout the human body, where it plays a fundamental role in hundreds of biological processes. The human body does not store zinc efficiently, making regular dietary intake essential for maintaining adequate levels.

Zinc is required as a cofactor for more than 300 metalloenzymes and over 1,000 transcription factors. It is critical for cell division, immune system function, protein synthesis, DNA synthesis, and wound healing. When zinc levels in the body become depleted, these processes are impaired, leading to a range of clinical manifestations including delayed wound healing, impaired immune response, skin lesions, and growth retardation in children.

Solvezink works by replenishing the body's zinc stores in patients who have been diagnosed with zinc deficiency. By restoring adequate zinc levels, the medication supports the body's natural healing mechanisms and enzymatic functions. The effervescent tablet formulation allows for rapid dissolution in water, facilitating absorption in the gastrointestinal tract.

Primary Indications

Venous leg ulcer healing: Solvezink is indicated for the treatment of venous leg ulcers (chronic wounds on the lower legs) in patients who have documented zinc deficiency. Zinc plays a central role in wound healing by promoting cell proliferation, collagen synthesis, and immune defense at the wound site. Studies have demonstrated that zinc-deficient patients with chronic wounds show improved healing rates when zinc levels are corrected through supplementation. The World Health Organization recognizes zinc as essential for wound repair, and zinc deficiency is a recognized cause of impaired wound healing.

Acrodermatitis enteropathica: This is a rare autosomal recessive genetic disorder caused by mutations in the SLC39A4 gene, which encodes a zinc transporter protein in the intestine. Patients with this condition cannot adequately absorb zinc from their diet, leading to severe zinc deficiency. Clinical manifestations include characteristic skin lesions (erythematous, vesiculobullous, and pustular dermatitis) typically appearing around body orifices and on the extremities, chronic diarrhea, hair loss (alopecia), and nail dystrophy. Without treatment, acrodermatitis enteropathica can be fatal. Lifelong zinc supplementation with products like Solvezink is the standard treatment, and symptoms typically resolve within days to weeks of initiating therapy.

Beyond these primary indications, zinc deficiency can occur in a variety of clinical settings including malabsorption syndromes, inflammatory bowel disease, liver cirrhosis, chronic kidney disease, sickle cell anemia, and in patients receiving long-term parenteral nutrition without adequate zinc supplementation. Patients with extensive burns, chronic diarrhea, or high-output fistulas are also at increased risk of zinc depletion.

What Should You Know Before Taking Solvezink?

Quick Answer: Do not take Solvezink if you are allergic to zinc sulfate or any of its excipients. Inform your doctor about all medications you take, especially antibiotics. Long-term use requires copper level monitoring.

Contraindications

Solvezink should not be taken if you have a known allergy (hypersensitivity) to zinc sulfate or to any of the other ingredients in the formulation, including sorbitol, saccharin sodium, mannitol, citric acid, sodium hydrogen carbonate, sodium carbonate, povidone, and sodium citrate. Allergic reactions to zinc sulfate are rare but can include skin rash, itching, and swelling.

Patients with hereditary fructose intolerance should not take Solvezink, as each effervescent tablet contains 115.5 mg of sorbitol, which is a source of fructose. Hereditary fructose intolerance is a rare genetic condition in which the body cannot properly metabolize fructose, and ingestion of fructose or sorbitol can cause severe hypoglycemia, liver damage, and metabolic acidosis. If you or your child has been diagnosed with this condition, contact your healthcare provider before using this medication.

Warnings and Precautions

The most important clinical consideration during zinc supplementation therapy is the potential for copper depletion. Zinc and copper compete for absorption in the gastrointestinal tract via shared transporters, and prolonged zinc supplementation at therapeutic doses can significantly reduce copper absorption. Copper deficiency can lead to serious hematological consequences including sideroblastic anemia, neutropenia (low white blood cell count), and neurological symptoms such as peripheral neuropathy and myelopathy.

Your doctor should monitor serum copper levels and ceruloplasmin (a copper-carrying protein) during prolonged treatment with Solvezink, particularly when using higher doses. If copper deficiency develops, your doctor may prescribe concurrent copper supplementation or adjust your zinc dose accordingly. The risk of copper depletion is dose-dependent and increases with treatment duration exceeding several months.

Sodium content: Each Solvezink effervescent tablet contains 106 mg of sodium (approximately 5% of the WHO-recommended maximum daily sodium intake of 2 grams for adults). This should be taken into consideration by patients on a sodium-restricted diet, such as those with hypertension, heart failure, or kidney disease. If you are taking three tablets daily, the total sodium contribution from Solvezink alone would be 318 mg, which may be clinically relevant for sodium-sensitive patients.

Pregnancy and Breastfeeding

There are no known risks associated with the use of Solvezink during pregnancy at recommended therapeutic doses. Zinc is in fact an essential nutrient during pregnancy, playing a critical role in fetal growth and development, organogenesis, and immune system maturation. The WHO recommends adequate zinc intake during pregnancy, and zinc deficiency during pregnancy has been associated with adverse outcomes including preterm birth, low birth weight, and prolonged labor.

Zinc passes into breast milk, but at therapeutic supplementation doses it is unlikely to adversely affect the nursing infant. Breast milk zinc concentrations are largely regulated by the mammary gland and remain relatively stable regardless of maternal zinc intake, except in cases of severe maternal depletion. Nevertheless, as with all medications during pregnancy and breastfeeding, it is advisable to consult your healthcare provider before starting or continuing Solvezink therapy.

Effects on Driving and Machine Operation

Solvezink is not expected to have any effect on your ability to drive vehicles or operate machinery. No impairment of alertness, reaction time, or cognitive function has been reported with zinc sulfate supplementation.

How Does Solvezink Interact with Other Drugs?

Quick Answer: Solvezink can reduce the absorption of fluoroquinolone and tetracycline antibiotics. Iron supplements and penicillamine also interact with zinc. Separate dosing by at least 2 hours to avoid interactions.

Drug interactions with zinc supplements are primarily pharmacokinetic in nature, occurring at the level of gastrointestinal absorption. Zinc can form insoluble chelate complexes with certain medications in the gut, reducing the bioavailability of both the interacting drug and zinc itself. Understanding these interactions is essential for optimizing the therapeutic benefit of all your medications.

Major Interactions

Fluoroquinolone antibiotics: Zinc forms chelate complexes with fluoroquinolone antibiotics including ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin, and ofloxacin. This interaction can reduce the absorption of fluoroquinolones by 30–50%, potentially leading to subtherapeutic antibiotic concentrations and treatment failure. If you are prescribed a fluoroquinolone antibiotic, take it at least 2 hours before or 4–6 hours after Solvezink.

Tetracycline antibiotics: Similar chelation interactions occur between zinc and tetracycline-class antibiotics including tetracycline, doxycycline, minocycline, and demeclocycline. The reduction in tetracycline absorption can be clinically significant. Separate dosing of zinc and tetracyclines by at least 2–3 hours.

Penicillamine: Zinc reduces the absorption of penicillamine, a chelating agent used in the treatment of Wilson disease, cystinuria, and rheumatoid arthritis. Take penicillamine at least 2 hours apart from zinc supplements.

Minor Interactions

Iron supplements: Iron and zinc compete for absorption via shared intestinal transport pathways (particularly the divalent metal transporter 1, DMT1). When taken simultaneously at high doses, iron can reduce zinc absorption and vice versa. If you need both iron and zinc supplementation, it is advisable to take them at different times of the day, preferably 2–3 hours apart.

Calcium supplements: High-dose calcium supplementation may modestly reduce zinc absorption, although this interaction is generally less clinically significant than the iron-zinc interaction. Separating doses is advisable for patients taking large calcium supplements.

Phytate-rich foods: While not a drug interaction per se, foods high in phytic acid (whole grains, legumes, nuts, and seeds) can bind zinc in the gut and reduce its absorption by up to 50%. Taking Solvezink immediately after a meal, as recommended, helps optimize absorption while minimizing gastrointestinal side effects.

What Is the Correct Dosage of Solvezink?

Quick Answer: Adults typically take 1 effervescent tablet (45 mg zinc) dissolved in a glass of water 3 times daily after meals. Pediatric dosing depends on body weight. Always follow your doctor's specific instructions.

Solvezink should always be taken according to your doctor's or pharmacist's instructions. The effervescent tablet should be dissolved completely in a full glass of water (approximately 200 ml) before drinking. Always take the dissolved tablet immediately after a meal to reduce the risk of nausea and other gastrointestinal side effects. Do not swallow the tablet whole or chew it.

Adults

Children

AE = Acrodermatitis enteropathica

Elderly

There is no specific dose adjustment recommended for elderly patients based on age alone. However, elderly patients are at increased risk of zinc deficiency due to reduced dietary intake, decreased intestinal absorption, chronic diseases, and polypharmacy. Your doctor will determine the appropriate dose based on your individual zinc levels, kidney function, and overall clinical condition. Elderly patients should be monitored more closely for potential copper depletion during long-term zinc therapy.

Missed Dose

If you forget to take a dose of Solvezink, take it as soon as you remember, provided it is still close to your usual dosing time. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to compensate for a forgotten one. Missing occasional doses is unlikely to significantly affect your treatment, but consistent daily dosing is important for maintaining therapeutic zinc levels.

Overdose

What Are the Side Effects of Solvezink?

Quick Answer: Common side effects include heartburn, nausea, and diarrhea (up to 1 in 10 people). These can be minimized by taking the tablet after food. Rare side effects include urticaria, rash, and itching.

Like all medicines, Solvezink can cause side effects, although not everybody gets them. The most commonly reported side effects are gastrointestinal in nature and are typically mild to moderate in severity. These effects are often dose-related and can be significantly reduced by taking the medication immediately after meals as directed.

Zinc sulfate can irritate the gastric mucosa when taken on an empty stomach, which is why the recommendation to take it after meals is particularly important. The effervescent formulation helps by providing a buffered solution, but gastric irritation can still occur, especially at higher doses. If gastrointestinal side effects persist despite taking Solvezink with food, consult your doctor about potentially reducing the dose or splitting it into smaller, more frequent administrations.

Long-Term Side Effects

With prolonged use of zinc supplements at therapeutic doses (particularly at 135 mg elemental zinc daily), there is a well-documented risk of secondary copper deficiency. This occurs because zinc induces the production of metallothionein in intestinal cells, which preferentially binds copper and prevents its absorption. Copper deficiency can manifest as:

• Sideroblastic anemia: A type of anemia caused by impaired copper-dependent iron metabolism
• Neutropenia: Decreased white blood cell count, increasing susceptibility to infections
• Peripheral neuropathy: Numbness, tingling, or weakness in the extremities due to nerve damage
• Myelopathy: Spinal cord dysfunction that can cause gait disturbances and weakness

Regular monitoring of serum copper and ceruloplasmin levels is recommended during long-term zinc therapy to detect copper depletion early. Your doctor may prescribe supplemental copper if deficiency develops.

How Should You Store Solvezink?

Quick Answer: Store in the original container, tightly closed after each use. Keep away from moisture. Do not use after the expiry date. Keep out of reach of children.

Proper storage of Solvezink is essential to maintain the quality and efficacy of the effervescent tablets. Zinc sulfate effervescent tablets are sensitive to moisture, and exposure to humidity can cause premature dissolution, tablet deterioration, and loss of potency.

Store in the original packaging. The plastic tube provides a moisture barrier that protects the effervescent tablets from ambient humidity. Always close the tube tightly after each use to prevent moisture ingress. Do not transfer the tablets to another container, pill organizer, or blister pack.

Keep out of the sight and reach of children. As with all medications, Solvezink should be stored where children cannot access it. Accidental ingestion of multiple zinc tablets by a child can cause acute zinc toxicity with severe gastrointestinal symptoms.

Do not use after the expiry date printed on the packaging. The expiry date refers to the last day of the stated month. Expired zinc sulfate tablets may have reduced potency and altered dissolution properties.

Disposal: Do not dispose of Solvezink in household waste or by flushing down the drain. Return unused or expired medication to your local pharmacy for safe disposal. Proper pharmaceutical waste disposal protects the environment from unnecessary chemical contamination of water systems and soil.

What Does Solvezink Contain?

Quick Answer: Each effervescent tablet contains zinc sulfate equivalent to 45 mg elemental zinc (Zn²⁺). Excipients include sorbitol, saccharin sodium, mannitol, citric acid, sodium bicarbonate, povidone, and sodium citrate.

Each Solvezink effervescent tablet contains one active ingredient and several inactive ingredients (excipients) that are necessary for tablet formation, effervescence, taste, and stability.

Active Ingredient

Zinc sulfate, providing 45 mg of elemental zinc (Zn²⁺) per tablet. Zinc sulfate is the most commonly used salt form for oral zinc supplementation due to its well-established bioavailability profile and extensive clinical evidence base. The zinc sulfate salt dissociates in solution to release zinc ions, which are then absorbed primarily in the duodenum and jejunum.

Inactive Ingredients (Excipients)

• Sorbitol (E 420): 115.5 mg per tablet. A sugar alcohol used as a sweetener. It is a source of fructose and should be avoided by patients with hereditary fructose intolerance.
• Saccharin sodium: An artificial sweetener providing additional sweetness without adding calories or affecting blood sugar.
• Mannitol: A sugar alcohol used as an excipient and filler in the tablet formulation.
• Anhydrous citric acid: Provides the acid component of the effervescent reaction when the tablet is dissolved in water.
• Sodium hydrogen carbonate (sodium bicarbonate): Reacts with citric acid to produce carbon dioxide, creating the effervescent (fizzing) effect upon dissolution.
• Anhydrous sodium carbonate: An additional alkaline component supporting the effervescent reaction and buffering capacity.
• Povidone: A binding agent that helps maintain tablet structural integrity.
• Sodium citrate: A buffering agent that helps regulate the pH of the dissolved solution, improving taste and tolerability.

Tablet Appearance

Solvezink effervescent tablets are white, round, and 18 mm in diameter. They are supplied in plastic tubes containing 25 tablets each, with 4 tubes per package (100 tablets total). The tablets should dissolve completely in water within a few minutes, producing a clear to slightly cloudy solution.

References

This article is based on the following international medical guidelines, peer-reviewed research, and official drug information sources:

1. World Health Organization (WHO). Zinc supplementation in the management of diarrhoea. WHO/UNICEF Joint Statement, 2004 (updated 2023). Geneva: WHO.
2. Cochrane Database of Systematic Reviews. Wilkinson EAJ. Oral zinc for arterial and venous leg ulcers. Cochrane Database Syst Rev. 2014;(9):CD001273. doi:10.1002/14651858.CD001273.pub3
3. European Medicines Agency (EMA). Guidelines on the clinical evaluation of medicinal products for wound healing. EMA/CHMP/96451/2021.
4. British National Formulary (BNF). Zinc sulfate monograph. National Institute for Health and Care Excellence (NICE). Accessed January 2026.
5. Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med. 2008;14(5-6):353-357. doi:10.2119/2008-00033.Prasad
6. Maverakis E, et al. Acrodermatitis enteropathica and an overview of zinc metabolism. J Am Acad Dermatol. 2007;56(1):116-124. doi:10.1016/j.jaad.2006.08.015
7. Plum LM, Rink L, Haase H. The essential toxin: impact of zinc on human health. Int J Environ Res Public Health. 2010;7(4):1342-1365. doi:10.3390/ijerph7041342
8. Nations SP, et al. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology. 2008;71(9):639-643. doi:10.1212/01.wnl.0000312375.01068.b2
9. Fosmire GJ. Zinc toxicity. Am J Clin Nutr. 1990;51(2):225-227. doi:10.1093/ajcn/51.2.225
10. WHO. Model List of Essential Medicines – 23rd list. World Health Organization, 2023.

Editorial Team

This article has been developed by the iMedic Medical Editorial Team and reviewed according to international medical standards.